First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|10|2|571-576

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.2, 2017-06, pp. : 571-576

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-01 ,pp. : 14-17

Karger

Access to resources Recommend Favorite

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-10 ,pp. : 711-717

Karger

Access to resources Recommend Favorite

Gemcitabine Plus Nab-Paclitaxel as Second-Line and Beyond Treatment for Metastatic Pancreatic Cancer: a Single Institution Retrospective Analysis

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 142-145

Bentham Science Publishers

Access to resources Recommend Favorite

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 252-259

Karger

Access to resources Recommend Favorite

Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine

By  

Oncology Research and Treatment, Vol. 38, Iss. 11, 2015-0 ,pp. : 596-603

Karger

Access to resources Recommend Favorite